Synbiobeta

Entrepreneur breaks down biology making experiments a breeze for scientists

It is fascinating to see how a bright young mind such as Max Hodak can become a powerful player in an industry such as biotech. A company like Transcriptic does not follow any of the traditional [...]

Dr. Douglas Densmore: The International Workshop on Bio-Design Automation

It is approaching that time of year again for the 6th annual International Workshop on Bio-Design Automation ( IWBDA). This event, which spans from June 11th-12th  in Boston, Massachusetts, brings together researchers, entrepreneurs, industrialists, and students [...]

The Science of Synbio Funding: One-on-one with Innovation Endeavor’s Zavain Dar

Written by Ron Kanter Computer Scientist and Venture Capitalist, Zavain Dar is the premier example of the mind behind the capital behind any one of Synthetic Biology’s successful startup companies. A member of the investment team [...]

Transcriptic, Rewriting the traditional wet-lab workflow

Although there is the saying: If you want it done right, do it yourself, there are plenty of times, where I know scientists wished they could pass off some of the nitty gritty lab work to a [...]

Dr. Andrew Spicer: Developing microalgae as novel chassis organisms for synthetic biology.

As the field of synthetic biology continues to grow, new organisms are being introduced into the space: Microalgae are one of them. For Dr. Andrew Spicer, Chief Research Scientist and Director of Algenuity “the big challenges [...]

What’s in Store Following the Genome Compiler and DNA 2.0 Settlement?

Approximately one year ago DNA 2.0 filed a lawsuit against Genome Compiler accusing the corporation of infringing certain patent agreements granted to DNA 2.0 in 2010. Just recently, the two companies reached a settlement in that Genome [...]

Dr. Rachel Haurwitz: Caribou Biosciences

Lately, CRISPR- mediated genome engineering has been making headlines in newspapers around the world, claiming that this is a revolutionary development that allows scientists to engineer any part of the human genome with extremely accurate precision. [...]

Interview with Jamie Bacher

Dr. Jamie Bacher took the time to interview with me on Monday to discuss his newly launched San Francisco-based start-up Pareto Biotechnologies, Inc. Pareto utilizes polyketide biosynthesis to create a potentially future-altering synthetic biology platform that [...]

Rob Carlson: Cowborgs are the Future of Energy

Written by Jonny Serfaty Rob Carlson is one of the world’s leading experts on biotechnology, particularly synthetic biology, and spends a lot of his time analyzing the industry in order to help biotech companies do well [...]

Biomonstaaar: A Bioreactor for Everyone

Sunny Allen was always interested in science, but overwhelming workloads and lack of encouragement led her to study linguistics instead. Five years of waitressing later, she decided to go back to school and start a second [...]

SynBioBeta: The Main Event for SynBio Industry

SynBioBeta describes itself as an activity hub for start-ups, industry and investors active in synthetic biology. With the next conference coming up in November, I spoke to founder John Cumbers about how it got started. “We were running a [...]